Outcome of Board Meeting

Arvee Laboratories (India) Limited. 403, Entice Building, Opposite Jayantilal Park BRTS Bus Stop, Iskcon — Bopal Road, Ambli, Ahmedabad 380 058, Gujarat, India a I- e e Phone: +91- 2717430479 | +91- 2717-410819 e-mail: info@arveelabs.com, Website: www.arveelabs.com LABORATORIES CIN No. :- L24231GJ2012PLC068778, Date: 7*" August, 2026 National Stock Exchange of India — Emerge Platform Mumbai Scrip Code: ARVEE ISIN: INEO06201016 Ref: Outcome of the Board Meeting held on 7'" August, 2026 Sub: Intimation under Regulation 30 read with Schedule Ill of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) Pursuant to Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 we would like to inform that in continuation of our letter dated 315t July, 2026, the meeting of the Board of Directors held today have interalia amongst others approved the following a) Unaudited standalone financial results for the period ended on 30" June, 2026 along with limited review report issued by Statutory Auditors of the Company. b) Scheme of Arrangement: The Board decided to postpone the Scheme of arrangement for better understanding of the matter. c) Appointed Mr. Alkesh Jalan, Company Secretary in practice as Scrutiniser for the purpose of Annual General Meeting. d) Approved the Directors Report for the year ended on 315t March, 2026. e) Fix the date, time and venue of Annual General Meeting. f) Approved the Notice calling Annual General Meeting. The Board Meeting started at fl: 00 p.m. and concluded atgwpm. Kindly take the above information on record. Thanking You, Managing Director Shalin Sudhakarbhai Patel DIN: 01779902 Arvee Laboratories (India) Limited. 403, Entice Building, Opposite Jayantiial Park BRTS Bus Stop, Iskcon — Bopal Road, Ambli, Ahmedabad 380 058, Gujarat, India Phone; +91- 2717430479 | +91- 2717410819 e-mail: info@arveelabs.com, Website: www.arveelabs.com LABORATORIES CIN No. :- L24231GJ2012PLC068778. ARVEE LABORATORIES (INDIA) LIMITED CIN: L24231GJ2012PLC068778 Registered Office: 403, Entice, Nr. Jayantilal Park BRTS, Iskcon Bopal Road, Ambli, Ahmedabad - 380058 Tel : +91 - 2717-430479 | | +91 - 2717-410819; Website : www.arveelabs.com; Email ID : compliance@arveelabs.com STATEMENT OF UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED ON JUNE 30, 2026 (T in Lakhs, except per share data) Sr. [Particulars Quarter ended Year ended No. 30/06/2026 | 31/03/2026 | 30/06/2025 | 31/03/2026 Un-Audited Audited Un-Audited Audited 1 |Revenue from Operations 1,722.53 1,080.41 748.00 3,151.41 2 [Other Income 18.09 14.63 16.87 68.11 3 |Total Revenue (1+2) 1,740.61 1,095.04 764.87 3,219.52 4 |Expenses Cost of material consumed 916.64 491.66 548.27 1,818.90 Changes in inventories of finished goods, work-in-progress and stock in trade 207.83 140.12 (206.34) (352.53). Employee benefit Expenses 155.31 102.07 167.59 446.87 Finance Costs 6.49 8.18 433 23.48 Depreciation and amortisation expenses 3227 931.3% 29.41 121.37 Other expenses 193.19 236.27 204.19 918.38 Total Expenses (4) 1,511.73 1,009.67 747.45 2,976.47 5 |Profit / (Loss) before exceptional items and tax (1-4) 228.88 85.37 17.42 243.04 6 |Exceptional items B = b - 7 |Profit / (Loss) before tax (5-6) 228.88 85.37 17.42 243.04 8 |Tax expense Current Tax 51.82 14.46 0.51 37.61 Deferred Tax 7.65 18.89 = (47.19) 9 |Profit / (Loss) for the period from continuing operations (7-8) 169.41] 52.02 16.91] 252.63 10 _|Profit / (Loss) from discontinued operations - 11 |Tax Expense of discontinued operations - 12 |Pro/ f(Liosts) from discontinued operations (after tax) (10-11) - 13 |Profit / (Loss) for the period (9+12) 169.41 52.02 16.91 252.63 14 |Other Comprehensive Income a. Items that will not be reclassified to profit or loss (Net of tax) - - - - b. Items that will be reclassified to profit or loss (Net of tax) - - - - 15 |Total Comprehensive Income for the period (13+14) 169.41 52.02 16.91 252.63 Paid-up equity share capital (Face Value of the Share Rs. 10/- each) 1102.00 1102.00 1102.00 1102.00 Arvee Laboratories (India) Limited. 403, Entice Building, Opposite Jayantial Park BRTS Bus Stop, Iskcon — Bopal Road, Ambli, Ahmedabad 380 058, Gujarat, India Phone: +91- 2717-430479 | +91- 2717410819 e-mail: info@arveelabs.com, Website: www.arveelabs.com LABORATORIES CIN No. :- L24231GJ2012PLC068778. Sr. |Particulars Quarter ended Year ended 30/06/2026 | 31/03/2026 | 30/06/2025 | 31/03/2026 Un-Audited Audited Un-Audited Audited 16_|Earnings per equity share (for continuing operation) Basic 1.54 0.47 0.15 2.29 Diluted 1.54 0.47 0.15 2.29 17 |Earnings per equity share (for discontinued operation) Basic = - - - Diluted - - - - 18 |Earnings per equity share (for continuing & discontinued operation) Basic 1.54] 0.47 0.15 229 Diluted 1.54 0.47 0.15 2.29 Paid-up equity share capital (Face value of ¥ 10 each) 1,102.00 1,102.00 1,102.00 1,102.00 Other Equity excluding Revaluation Reserve 2,446.18 2,276.77 2,041.05 2,276.77 Notes: 1 The aforesaid Financial Results for the quarter ended June 30, 2026 have been reviewed by the Audit Committee and subsequently approved by the Board of Directors at its Meeting held on Friday, August 07, 2026. The Statutory Auditors of the Company have carried out a Limited Review of the aforesaid results. 2 The aforesaid Financial Results for the quarter ended June 30, 2026 have been prepared in accordance with Companies (Indian Accounting Standard) Rule, 2015 as prescribed under Section 133 of the Companies Act, 2013 read with relevant rules issued thereunder and in terms of Regulation 33 and Regulation 52 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. 3 In line with Ind AS - 108 Operating Segments and basis of the review of operations being done by the Senior Management, the operations of the Company fall under the Chemicals business which is considered to be the only reportable segment by the management. 4 Figures for the quarter ended on 30th June, 2026 and Year ended on 31st March, 2026 the Company has adopted Ind AS. The adoption of the standard did not have any material impact to the financial statements of the Company. 5 The figures for the corresponding Previous period have been restated / regrouped wherever necessary, to make them comparable. 6 There has been transfer of assets from the Textile Chemical Segment ( films and fibres ) to Non - Textile Chemical Segment based upon the operational aspects. For and on behalf of Board of Directors of ARMVEE oLABOoRATO RIE1S 1(IN2DIA2) L IMITED SHALIN SUDHAKARBHAI PATEL CHAIRMAN CUM MANAGING DIRECTOR DIN: 01779902 Date: August 07, 2026 Place: Ahmedabad ARVEE LABORATORIES (INDIA) LIMITED CIN: L24231GJ2012PLC068778 Registered Office: 403, Entice, Nr. Jayantilal Park BRTS, Iskcon Bopal Road, Ambli, Ahmedabad - 380058 Tel : 491 - 2717-430479 | |+91 — 2717-410819; Website : www.arveelabs.com; Email ID : compliance@arveelabs.com STATEMENT OF UN-AUDITED FINANCIAL RESULTS FOR THE YEAR ENDED ON JUNE 30, 2026 (T in Lakhs) Segment wise Revenue, Results & Capital Employed Quarter ended No. Particulars 30/06/2026 Un-audited 1 |SEGMENT REVENUE A) Textile Chemical Segment (Films & Fibre) 230.58 B) Non-textile Segment 1,510.03 TOTAL 1,740.61 Less: Inter Segment Revenue - Net Sales/Income From Operations 1,740.61 2 [SEGMENT RESULTS Profit / (Loss) before Tax and Interest from A) Textile Chemical Segment (Films & Fibre) 29.99 B) Non-textile Segment 204.96 TOTAL 234.95 Less: i) Interest Expenditure 6.07 ii) Other Unallocable Expenditure Net Off Unallocable Income - TOTAL PROFIT BEFORE TAX 228.88 3 |CAPITAL EMPLOYED (Segment Assets - Segment Liabilities) A) Textile Chemical Segment (Films & Fibre) 422.80 B) Non-textile Segment 3,154.80 Capital Employed in Segments 3,577.60 ADD: Unallocable Corporates Assets Less Corporate Liabilities - TOTAL 3,577.60 For and on behalf of Board of Directors of ARVEE LABORATORIES (INDIA) LIMITED SHALIN SUDHAKARBHAI PATEL CHAIRMAN CUM M [Showing first 8,000 characters — download PDF for full document]